M2MMA advances M2Intel to MVP phase amid advisory, partnership push

By AI, Created 2:11 PM UTC, June 03, 2026, /AGP/ – M2MMA said it moved its M2Intel platform into the MVP phase in June 2026 and added advisers, partnerships and media visibility across the first half of the year. The update also set up an August presentation at the Association of Boxing Commissions conference and second-half development of M2Lab and M2Coach.

Why it matters: - M2MMA is trying to turn combat-sports safety and compliance into a unified technology stack. - The company says M2Intel is now moving from prototype to a market-ready platform. - The update points to a broader push to win credibility with regulators, promoters and medical stakeholders.

What happened: - M2MMA issued a corporate update on June 3, 2026, from Dubai. - The company said it made significant progress in the first half of 2026. - M2MMA said M2Intel advanced into the MVP phase in June 2026. - The company said third-party testing of M2Intel is scheduled for completion this month. - M2MMA completed its ticker symbol change to MMAZ on Feb. 19, 2026. - The stock now trades under $MMAZ.

The details: - M2MMA added former Association of Boxing Commissions President Michael Mazzulli to its advisory board. - M2MMA added combat-sports official “Big” John McCarthy to advise on AI tools for officials, athlete performance and safety protocols. - Dr. Dragan Zeljic joined the advisory board to support governance architecture for M2Intel and M2Chain. - Dr. Kyle Daigle joined to strengthen medical and neurological oversight. - Dr. Thomas Bottiglieri joined to support M2Lab research and athlete performance and well-being tools on M2Intel. - M2MMA said the advisory additions bring expertise across regulation, medicine, neuroscience and combat sports operations. - M2MMA announced a partnership with the Interdisciplinary Association of Functional Neurosciences and Rehabilitation to integrate accredited functional neurologists into the platform. - The company entered a technology partnership with The Reson8 Frequency System Inc. to explore AI-driven personalized frequency treatments in combat sports. - M2MMA established a partnership with NeuroSolution Center for neurological evaluations and recovery services. - M2Intel is designed to consolidate pre-fight medical requirements, fight-night checks and drug testing in one system. - The platform’s AI engine is designed to analyze aggregated medical and performance data to inform safety protocols and performance standards. - The regulatory suite will include an Officials Registry and a Physician Registry. - Dr. Michael Schwartz, co-chair of the ABC Medical Committee, is supporting the Physician Registry effort. - M2Intel is built on M2Chain, M2MMA’s proprietary blockchain technology, to create a secure and verifiable audit trail for combat-sports and medical data. - M2MMA was featured in ArabsMMA in an article titled “Inside M2MMA: Technology, Safety and the UAE’s Growing Role in Combat Sports.” - General Manager Chris Cannon appeared on Headfirst: A Concussion Podcast in an episode about combat sports and AI in concussion management. - Chris Cannon also appeared on The Neurologic Wellness Podcast in an episode titled “Brain Health In Mixed Martial Arts with Chris Cannon of M2MMA.” - Southpaw JS Substack published a feature titled “Introducing M2MMA: The AI-Driven Future of Fighter Safety and Combat Sports.”

Between the lines: - M2MMA is positioning itself as both a technology company and a standards-setting partner for combat sports. - The advisory board mix suggests the company wants validation from regulators, doctors and officials as much as from investors. - The media push appears aimed at building awareness before the company presents its platform to industry stakeholders. - Jeff Robinson said the company is also pursuing planned uplisting and a dedicated investor relations firm.

What’s next: - M2MMA will present the full ecosystem in August 2026 at the 38th Annual Conference of the Association of Boxing Commissions and Combative Sports in Orlando. - The company has been selected to present on “Combat Sports and AI Integration” at the conference. - In the second half of 2026, M2Lab development is set to begin. - M2Lab will focus on real-time impact monitoring and research into factors influencing traumatic brain injury risk. - M2Coach will begin rolling out through M2Intel in the second half of 2026. - M2Coach will cover training, nutrition, cognitive function, financial literacy and career management. - M2MMA said the next phase of growth will center on athlete safety, operational efficiency and commercial viability for combat sports events.

The bottom line: - M2MMA is moving from concept to product, with M2Intel now in MVP testing and a broader ecosystem lined up for rollout later in 2026.